In order to stimulate innovation, health claims which are based on newly developed scientific evidence and/or which include a request for the protection of proprietary data shall undergo an accelerated type of authorisation.
Recital 5, Commission Regulation (EU) No 851/2013 of 3 September 2013 authorising certain health cl…
In forcesince 3 Sep 2013